Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Genpharm logo — The leading partner of choice for Rare Disease market access...

Genpharm

The leading partner of choice for Rare Disease market access in the MENA Region. Commit . Connect . Cure

Founded 2012 United Arab Emirates United Arab Emirates 98 employees Health Care, Marketing

General Information

Company Name Genpharm
Founded Year 2012
Location United Arab Emirates United Arab Emirates +3
Employees 98
Industries Health Care, Marketing
Social

Get notified when Genpharm moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Genpharm

Genpharm is a significant player in the MENA region, specializing in Rare Disease market access. Since its establishment in 2012, the company has been dedicated to providing efficient and sustainable market entry solutions for Rare Disease and specialty pharmaceutical companies aiming to expand into the Middle East and North Africa. With a strong emphasis on evidence-based medicine and ethical standards, Genpharm operates from its bases in Dubai Science Park, U.A.E., and Boston, as well as an office in Ireland. The company's expertise lies in Gene Therapy, making it a unique regional entity. It leverages a team of highly qualified MSLs and KAMs, offering regulatory, medical, PV, and logistical support. Additionally, Genpharm capitalizes on its extensive local business knowledge and a vast network of trusted partners to create market opportunities for innovative healthcare products and services. Its current partners include Novartis Gene Therapy, Orchard Therapeutics, Sarepta, PTC, Ultragenyx, Amicus, Argenx, LEO Pharma, Albireo, and Quoin. For further insights into Genpharm's business model and the Middle East pharmaceutical market, interested parties can visit www.genpharmservices.com.

Taxonomy: Rare Disease Market Access, Specialty Pharmaceuticals, Gene Therapy Expertise, Pharmaceutical Market Strategy, Market Access Solutions, Regulatory Support, Medical Support, PV Support, Logistical Support, Orphan Drugs, Neuromuscular Diseases, Cell Therapy, Pharmaceutical Consultancy, Reimbursement Strategy, Middle East Pharmaceutical Market

No funding data available for Genpharm yet.

Get notified when Genpharm raises funding

Genpharm Alternatives & Competitors

Genpharm vs
Excellence Healthcare Services
Excellence Healthcare Services United Arab Emirates

A specialty healthcare marketing and consulting company

6 employees
Marketing
Genpharm vs
Croma
Croma Greece

From submission to prescription we break the market access barriers

15 employees
Pharmaceutical, Marketing
Genpharm vs
PRA Consultancy
PRA Consultancy United Arab Emirates

Professionals Regulatory Affairs

26 employees
Health Care, Pharmaceutical

FAQ About Genpharm

The leading partner of choice for Rare Disease market access in the MENA Region. Commit . Connect . Cure
Genpharm was founded in 2012.
Genpharm is headquartered in United Arab Emirates.
Genpharm operates in the following industries: Health Care, Marketing.
Genpharm has approximately 98 employees.
Top alternatives and competitors to Genpharm include Excellence Healthcare Services, Croma, PRA Consultancy, Biopharma-mea, Morgan Prestwich - Life Science & Healthcare Executive Search. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Genpharm and Excellence Healthcare Services are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Genpharm and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes